Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
288 participants
INTERVENTIONAL
2023-11-15
2026-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control
NCT06067399
Morbidity in Newly Diagnosed type2 Diabetes in Adults
NCT02002091
Coronary Artery Disease Severity in Newly Diagnosed Dysglycemia
NCT05210972
An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa
NCT05317845
An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes
NCT03811288
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A diversification in non-fatal conditions in people with DM has also been reported. This is attributable to broader, non-vascular conditions. Due to increasing longevity among people with type 2 DM with increasing and diversifying multimorbidity in them, the health needs of people with Type 2 DM are therefore likely to be broad, and complex.
Finding multimorbidity (two or more chronic conditions) is common in people with Type 2 DM and increasing, but the comorbidity profiles of people with T2DM vary substantially.
Many studies have primarily focused on identifying multimorbidity patterns in the general population.
The understanding of multimorbidity patterns and composition of specific comorbidities in people with DM, and how this varies across patient groups and during the course of the disease, is limited. Further knowledge of this could provide insight into providing more holistic and more personal approaches to clinical guideline development, care pathways, and secondary prevention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
type 2 DM
HBA1C
blood sample on EDTA
Lipid profile, including total, LDL, and HDL cholesterol and Triglycerides
serum sample
Urine analysis and urinary albumin-to-creatinine ratio
Morning urine sample
Serum creatinine and estimated glomerular filtration rate
serum sample
Complete blood count
blood sample on EDTA
Thyroid-stimulating hormone
serum sample
Serum iron, TIBC, Transferrin saturation and serum ferritin if needed
serum sample
Electrocardiography (ECG)
by electrocardiogram
Transthoracic echocardiography, Neck ultrasonography if needed and abdominopelvic ultrasound
imaging
Arterial duplex ultrasound of both lower limbs
imaging
Random blood glucose
serum sample
AST, ALT, albumin
serum sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HBA1C
blood sample on EDTA
Lipid profile, including total, LDL, and HDL cholesterol and Triglycerides
serum sample
Urine analysis and urinary albumin-to-creatinine ratio
Morning urine sample
Serum creatinine and estimated glomerular filtration rate
serum sample
Complete blood count
blood sample on EDTA
Thyroid-stimulating hormone
serum sample
Serum iron, TIBC, Transferrin saturation and serum ferritin if needed
serum sample
Electrocardiography (ECG)
by electrocardiogram
Transthoracic echocardiography, Neck ultrasonography if needed and abdominopelvic ultrasound
imaging
Arterial duplex ultrasound of both lower limbs
imaging
Random blood glucose
serum sample
AST, ALT, albumin
serum sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Patients with secondary diabetes.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New Valley University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asmaa Nady Hussein
Lecturer of Internal Medicine and Clinical Hematology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New Valley University
Al KhÄrjah, Kharga Oasis, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.
Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL, Imperatore G. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet. 2018 Jun 16;391(10138):2430-2440. doi: 10.1016/S0140-6736(18)30314-3. Epub 2018 May 18.
Harding JL, Shaw JE, Peeters A, Davidson S, Magliano DJ. Age-Specific Trends From 2000-2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People. Diabetes Care. 2016 Jun;39(6):1018-26. doi: 10.2337/dc15-2308. Epub 2016 Apr 26.
Pearson-Stuttard J, Bennett J, Cheng YJ, Vamos EP, Cross AJ, Ezzati M, Gregg EW. Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol. 2021 Mar;9(3):165-173. doi: 10.1016/S2213-8587(20)30431-9. Epub 2021 Feb 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CODM2KNV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.